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ABSTRACT
Objective: To detect the various of H. pylori genotypes, determine the most prevalent one, and to identify the determi-
nants of disease severity.
Methods: Biopsies from 90 patients were collected, however 69 were exclusively analyzed. Recognition of H. pylori was 
made by rapid urease test, histopathology and polymerase chain reaction. The latter was used to amplify genes encod-
ing for virulence markers such as CagA, vacAs1 and vacAs2. 
Results: cagA was identified in 45 isolates (65.2%), vacAs1 in 54 (78.3%, predominantly vacAs1a), vacAs2 in 15 (21.7%), 
vacAm1 in 37 (53.6%), vacAm2 in 32 (46.4%), vacAi1 in 36 (52.2%), and vacAi2 in 32 (46.4%) of strains. vacAi1 gene was 
the only independent marker of pathogenicity. cagA/vacAs1(a)i1m1 was the most prevalent genotype. 
Conclusion: isolates possess vacAs1(a) as the predominant allelic variant of vacAs types, with a closely equal distribu-
tions of m1 and m2 alleles and of i1 and i2 alleles. The majority of the strains from the population studied are of the 
cagA/vacAs1(a)i1m1 genotype. vacAi1 is the only determinant of disease severity. J Microbiol Infect Dis 2013; 3(3): 109-
115
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Mısır’da bir üniversite hastanesinde hastalar arasında Helicobacter pylori genotipleri: 
hastalığın ciddiyet belirteçlerinin belirlenmesi
ÖZET
Amaç: Çeşitli H. pylori genotiplerini saptamak, en yaygın olanı belirlemek ve hastalığın ciddiyetini gösteren belirteçleri 
saptamak
Yöntem: Doksan hastadan alınan biyopsiler toplandı ancak bunlardan sadece 69’u analiz edildi. H. pylori tanınması hızlı 
üreaz testi, histopatoloji ve polimeraz zincir reaksiyonu ile yapıldı. Bu sonuncu aynı zamanda CagA, vacAs1 ve vacAs2 
gibi virülans belirteçlerini kodlayan genleri amplifiye etmek için kullanıldı.
Bulgular: cagA 45 suşta (% 65,2), vacAs1 54 suşta (% 78,3, ağırlıklı olarak vacAs1a), vacAs2 15 suşta (% 21,7), vacAm1 37 
suşta (% 53,6) olarak, vacAm2 32 suşta (% 46,4), vacAi1 36 suşta (% 52,2) ve vacAi2 32 (% 46,4) tespit edildi. vacAi1 geni 
patojenite ile ilgili tek markerdı. cagA/vacAs1 (a) i1m1 geni en yaygın genotip idi.
Sonuç: m1 ve m2 alelleri ve i1 ve i2 alellerinin çok yakın eşit dağılımları ile vacAs tipleri içinde vacAs1(a) genine sahip 
olan izolatlar en baskın alelik varyant idi. Çalışılan suşların büyük çoğunluğu cagA/vacAs1(a)i1m1 genotipinde idi. Has-
talığın ciddiyetini gösteren tek tek belirteç vacAi1 idi.
Anahtar kelimeler: H. pylori, vacAs, vacAi, cagA, gastroduodenal hastalıkAmer FA, et al. Helicobacter pylori genotypes 110
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INTRODUCTION
H. pylori is a fastidious, microaerophilic, spiral 
gram-negative bacterium. It is an important human 
pathogen causing a variety of gastroduodenal dis-
eases; as chronic gastritis, peptic ulcer and gastric 
cancer. It is also associated with the development of 
MALT lymphoma.1 The ecological niche of H. pylori 
is the human stomach, where it establishes long-
term colonization of the gastric mucosa. Lifetime 
persistence of H. pylori within its host is the norm, 
with rare spontaneous clearance. Transmission can 
occur by contaminated water and indirect person to 
person contact e. g., via poorly disinfected endo-
scopes. 
H. pylori possess several potential virulence 
factors. The imbalance between the host defense 
mechanisms and these factors leads to ailment. 
The variation in disease outcome is probably due to 
differences in bacterial virulence genes. The most 
intensively studied virulence factors are the cytotox-
in-associated antigen (cagA), and the vacuolating 
cytotoxin (vacA).
The cagA gene is one of several genes in a 
pathogenicity island known as cagPAI, in the H. 
pylori genome. The cagA gene encodes for a pro-
tein that causes a number of cellular changes. It 
has been reported that most cagA-positive strains 
carry all of the other genes of the cagPAI, but all 
cagA-negative strains lack the cagPAI.2 Based on 
these findings, there is a general consensus that 
the presence of cagA is the marker for the presence 
of the cagPAI. In comparison with cagPAI-negative 
strains, infection with cagPAI-positive strains of H. 
pylori may significantly increase the risk of develop-
ing severe gastric mucosal inflammation, duodenal 
ulceration and gastric cancer.3
VacA, encoded by the vacA gene induces the 
formation of pores and anion channels in epithe-
lial cell membranes with vacuoles formation. It has 
also been described as a permease that promotes 
urea diffusion across epithelia providing an addi-
tional source of nutrients to sustain H. pylori growth 
in vivo. This cytotoxin can induce apoptosis in epi-
thelial cells and a specific inhibition of immune re-
sponse. vacA gene is present in all H. pylori, but is 
not similarly expressed.4 The gene contains a num-
ber of polymorphisms: signal (s), intermediate (i) 
and middle (m) regions. Each of these polymorphic 
regions has two main types/alleles that divide them 
further into type/allele 1 and type/allele 2.5 Within 
the ‘s1’ type, several subtypes are distinguished 
(s1a, s1b and s1c). The ‘s1’ type has more ability 
to form membrane channels than ‘s2’ type. The m1 
type shows toxicity to a broader range of cells than 
the m2 type. The i1 type has stronger vacuolating 
activity than the i2 type. More recently, a new inter-
mediate variant (i3) has been reported.6 The vari-
ations in the three regions of the vacA gene, are 
known to cause different vacuolating activities, and 
consequently disease progression.
Although H. pylori have a global distribution, 
several reports have evidenced geographical differ-
ences in the prevalence of cagA status and vacA 
alleles among H. pylori isolates. To our knowledge, 
there is only one study done in Egypt, 7 focusing 
on H. pylori virulence factors. However, that study 
addressed only cagA in relation to clinical presenta-
tion. The objectives of this work were to detect the 
various  H. pylori genotypes, determine the most 
prevalent one(s), and identify the determinants of 
disease severity. 
Patients and methods
Inclusion criteria: Ninety patients who underwent 
standard gastroscopy procedures were included 
in this study. Exclusive criteria: Patients who had 
received antibiotics, proton-pump inhibitors or 
NSAIDs, throughout the last 2 months were ex-
cluded. The symptoms of patients reported were 
abdominal pain and discomfort, changes in bowel 
habits, weight loss, loss of appetite, nausea and/or 
vomiting, melena, and bloating. Of these patients, 
50 had gastritis, 15 had gastric ulcer, 15 had duode-
nal ulcer, and 10 had gastric carcinoma.
Six gastric biopsies; 3 antral and 3 corpal were 
collected from each patient (Pentax Video–Endos-
copy EG/3485). The study has been approved by 
the Institutional Review Board. Written consent was 
obtained from all patients before biopsy collection. 
A set of one antral and one corpal biopsies were 
inserted into rapid urease test tube.8 The second 
set was dispatched in 10% buffered formalin, and 
processed for histopathologic examination using 
hematoxyline-eosin, and Giemsa stains.9 The PCR 
set was placed in 0.9% normal saline. 
For PCR, DNA was extracted from biopsies 
by QIAamp DNA Mini Kit (Qiagen, Germany). Ex-
tracted DNA was stored at -20°C until used for iden-
tification of ureA gene, and detection of virulence 
markers; cagA2 and vacA alleles [vacAs, vacAm, 
and vacAi], and subtypes.5,10,11 Primers used are 
shown in Table 1. Amplification was carried out in 
a final volume of 25 μL containing 12.5 μL master 
mix (Qiagen, Germany), 0.2 μM of each primer and 
10 ng of DNA. Amplification cycles were performed 
with Cyclogene Thermal Cycler (Techne, England), 
as mentioned elsewhere.5,7-9 For each batch of Amer FA, et al. Helicobacter pylori genotypes 111
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PCR reactions a positive internal control amplifying 
the human housekeeping gene glyceraldehydes-
3-phosphate dehydrogenase (GAPDH),12 and a 
negative control were included. PCR products were 
analyzed in parallel with a DNA MW-marker (Fer-
mentas) by electrophoresis on 2% agarose gel.
Table 1. Primers used in analysis of H. pylori ureA, cagA and vacA alleles and subtypes
Region amplified Primer designation Primer sequence (5’ to 3’) PCR product size
ureA HPU1
HPU2
5’-GCCAATGGTAAATTAGTT-3’
5’-CTCCTTAATTGTTTTTAC-3’10 411 bp
CagA cagA1
cagA2
5’-ATAATGCTAAATTAGACAACTTGAGCGA-3’
5’-AGAAACAAAAGCAATACGATCATTC-3’ 2 298 bp
vacAs1
VA1-F
VA1-R
5’-ATGGAAATACAACAAACACAC-3’
5’-CTGCTTGAATGCGCCAAAC-3’11 259 bp
S1a SS1-F
VA1-R
5’-GTCAGCATCACACCGCAAC-3’
5’-CTGCTTGAATGCGCCAAAC-3’11 190-bp
S1b SS3-F
VA1-R
5’-AGCGCCATACCGCAAGAG-3’
5’-CTGCTTGAATGCGCCAAAC-3’11 187-bp
vacAs2 VA1-F
VA1-R
5’-ATGGAAATACAACAAACACAC-3’
5’-CTGCTTGAATGCGCCAAAC-3’11 286 bp
vacA m1 VA3-F
VA3-R
5’-GGTCAAAATGCGGTCATGG-3’
5’-CCATTGGTACCTGTAGAAAC-3’ 11 290 bp
vacA m2 VA4-F
VA4-R
5’- GGAGCCCCAGGAAACATTG-3’
5’- CATAACTAGCGCCTTGCAC-3’ 11 352 bp
vacA i1
Vac-F1
C1R
5’-GTTGGGATTGGGGGAATGCCG-3’
5’-TTAATTTAACGCTGTTTGAAG-3’5 426- bp
vacA i2
Vac-F1
C2R
5’-GTTGGGATTGGGGGAATGCCG-3’
5’-GATCAACGCTCTGATTTGA-3’5 432- bp
A patient with H. pylori infection was defined as 
the patient diagnosed by the clinician, and having a 
positive result for any of the three diagnostic tests.
Descriptive statistical analysis for categorical 
variables was expressed as numbers and percent-
ages. The association between H. pylori virulence 
markers, and the association between markers (sep-
arate or in combination) and the clinical outcomes, 
were analyzed using Chi-square and Fisher’s ex-
act tests when expected values were less than 5. 
Moreover, we identified the virulence markers which 
can be considered as predictors of pathogenicity, 
using backward stepwise logistic regression analy-
ses. For that purpose, cases of gastric and duode-
nal ulcers (PUD), and malignancy, were analyzed 
separately in relation to gastritis. Odds Ratio and 
95% confidence interval were calculated. P <0.05 
was considered significant. Statistical analysis was 
conducted by using SPSS version.11
RESULTS
The age, gender and clinical picture of the 90 pa-
tients studied, are shown in Table 2. Eighty-two 
(91%) patients were found positive for H. pylori. Six-
ty-five (79%) were positive by the rapid urease test, 
68 (83%) were positive on histopathologic examina-
tion, and all (100%) were positive by PCR.
Table 2. Characters of the patients studied
Patients characters (n=90) Number (%)
Sex
   Males
   Females
51 (56.67%)
39 (43.33%)
Age (years) 16-69 (mean 40.5)
Signs and symptoms
   Abdominal pain and discomfort
   Changes in bowel habits
   Weight loss
   Loss of appetite
   Nausea and/or vomiting
   Melena
   Bloating
70 (77.78%)
54 (60%)
23 (25.56%)
11 (12.22%)
7 (7.78%)
4 (4.44%)
4 (4.44%)
Fifty-three H. pylori strains were cagA-positive. 
The vacAs gene was amplified in all isolates. Fifty-
three isolates had vacAs1, and the remaining 29 
had vacAs2 alleles. vacAm1 alone was identified in 
37 isolates, vacAm2 alone in 32 isolates, while both 
vacAm1 and vacAm2 were identified in 13 isolates. Amer FA, et al. Helicobacter pylori genotypes 112
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vacAi1 was found in 42 and vacAi2 in 39 isolates. 
Because each H. pylori isolate possesses a single 
copy of various vacA types, the detection of more 
than one type (s, i, or m) in a DNA sample indicates 
colonization by two or more isolates with dissimi-
lar vacA genotypes. Accordingly, only 69 isolates 
were subjected to further studies. The incidence of 
virulence markers, their association with disease 
outcome and the statistical analyses are shown in 
Table 3.
Table 3. Virulence markers and their association with disease outcome
Virulence marker
(n=69) (%)
Gastritis
 (n=29) n (%)
Gastric ulcer
(n=15) n (%)
Duodenal ulcer
(n=15) n (%)
Gastric carcinoma
 (n=10) n (%)
Total (69) P
cagA (65.2) 15 (51.7) 10 (66.7) 11 (73.3) 9 (90.0) 45 0.140
vacAs1 (78.3) 19 (65.5) 12 (80.0) 13 (86.7) 10 (100) 54 0.102
vacAs1a (72.5) 17 (58.6) 12 (80) 12 (80) 9 (90) 50 0.159
vacAs1b (7.2) 2 (6.9) 1 (6.7) 1 (6.7) 1 (10) 5 0.988
vacAs2 (21.7) 10 (34.5) 3 (20.0) 2 (13.3) 15 0.102
vacAm1 (53.6) 5 (17.2) 11 (73.3) 12 (80) 9 (90) 37 <0.001*
vacAm2 (46.4) 24(82.8) 4 (26.7) 3 (20) 1 (10) 32 <0.001**
vacAi1 (52.2) 3(10.3) 12 (80) 12 (80) 9 (90) 36 <0.001*
vacAi2 (46.4) 25 (86.2) 3 (20) 3 (20) 1 (10) 32 <0.001**
* significant towards increased pathogenicity
** significant towards less pathogenicity
Figure 1. Amplification products of  cagA and vacA alleles and subtypes, and genotypes of 6 strains (24-29), isolated 
from gastritis).
Primers used are: 1) cagA gene: cagA1 and cagA2 ; 2) vacAs1a gene: SS1-F and VA1-R ; 3) vacAs1b: SS3-F and 
VA1-R;  4) vacAm1 gene: VA3-F and VA3-R;  5) vacAm2 gene: VA4-F and VA4-R;  6) vacAi1 gene: Vac-F1 and C1R; 
7) vacAi2 gene: Vac-F1 and C2R;  8) vacAs2 (not shown in figure: SS2-F and VA1-R).
Genotypes of isolated strains: 24: cagA/vacAs1(a)/i2/m2, 25: vacAs1(a)/i2/m1/m2 (excluded from analysis) 26: 
vacAs1(b)/i2/m1/m2 (excluded from analysis), 27:cagA/vacAs1(a)/i1/m1, 28:vacAs2/i2/m2, 29: cagA/vacAs1(a)/i2/m2.Amer FA, et al. Helicobacter pylori genotypes 113
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The virulence markers which appeared to be 
statistically associated with disease outcomes, as 
shown in Table 3, were introduced into a backward 
stepwise logistic regression study, vacAi1 was 
found to be the only independent marker of patho-
genicity. The strongest association was with malig-
nancy [OR 77.99 (CI 7.7-848.5), p<0.001]. For PUD 
the OR was 34.7 (7.79-154.3), p<0.001). 
In this work, all possible associations existed 
among allelic variants of H. pylori, except for va-
cAs2, as seen in Table 4 and Figure 1. The majority 
of our isolates, were cagA/vacAs1(a)/i1/m1 geno-
type. The distribution of various genotypes and 
the statistical significance of such distribution are 
shown in Table 4.
Table 4. Genotypes of H. pylori isolates
vacA
status
cag A
positive
cag A
negative Total P
s1a/i1/m1
s1b/i1/m1
29†
2
3
1
32
3
<0.001**
1**
s1/i2/m1 0 1 1 0.35
s1/m2
s1/i1/m2
s1/i2/m2
0
13
1
3
1
16
0.35
0.11
s2/i2/m2 0 15 15 <0.001***
Total 44 24 68
† the most prevalent genotype: cagA/s1(a)/i1/m1
*A significant association between the presence of cagA 
and being of the vacAs1i1m1 genotype. 
** cagA+ strains were more likely to be vacAs1a, than va-
cAs1b. 
***Statistically  significant  relationship  between  vacA-
s2i2m2 genotype and absence of cagA.
DISCUSSION
More than half of the population worldwide, are 
persistently infected with H. pylori.13 In developing 
countries, 70-90% of the population harbors this or-
ganism; and the majority acquire the infection be-
fore the age of 10 years. In developed countries, 
the prevalence is less, due to better socioeconomic 
circumstances. 
In the current work, eighty-two (91%) patients 
were found to have H. pylori. This high rate may 
be due to the fact that our hospital is a tertiary-care 
facility with a large number of patients being diag-
nosed, and referred through primary and secondary 
care facilities.
Despite the worldwide existence of H. pylori, a 
noteworthy genetic dissimilarity is evident among 
different geographic areas. The incidence of cagA-
positive strains differs in various parts of the world, 
and there is a clear regional variation in the distribu-
tion of vacA alleles and subtypes.
Among our isolates, a high incidence of ca-
gA-positive strains was detected, as in Table 3, 
which is comparable to the results obtained in of 
a recent study conducted in Minofya Egypt 7. East 
Asian, U.S. African, and Western European, Latin 
American and Lebanese strains have been shown 
to have cagA positivity of nearly 100% 14, 80% 15 
60 to 70%16,17 and 37.5%18, respectively. As to the 
Middle East, a wide range of cagA distribution has 
been identified. The lowest has been from Jordan, 
(26.4%), and the highest from Kuwait (87%). Those 
from Saudi Arabia, Iraq, Iran, and Turkey (52%, 
71%, 76%, and 78% respectively) fall in between.19
When the prevalence of cagA has been linked 
to the clinical presentations, a direct relation has 
been found. While it was the lowest in gastritis, it 
was the highest in gastric carcinoma, as shown 
in Table 3. The same was recognized in Minofya, 
Egypt9 and another study from Iran.20 On the other 
hand, studies from Europe and North America re-
ported  a  significant  correlation  between  the  pos-
session of cagA and the risk of developing atrophic 
gastritis, peptic ulcer diseases and gastric cancer.3
We analyzed the vacAs, vacAm, and vacAi re-
gions separately. A higher rate of vacAs1 than va-
cAs2 allele was encountered, which goes in con-
sonance with reports elsewhere.19 Similar to data 
from Northern and Eastern Europe21, the majority 
of our vacAs1 alleles was of the vacAs1a subtype, 
whereas in Spain, Portugal, Central America, and 
Brazil 89% of strains are of the vacAs1b subtype.22 
The distribution of vacAs1a and vacAs1b varies 
also between different areas in the same country, 
as in Pakistan and Chilli.23,24
Contradictory to studies demonstrating a high-
er risk for development of peptic ulcer disease upon 
gastric infection with H. pylori strains containing 
type vacAs1 allele/subtypes25, we found that this 
correlation is non-significant, as shown in table 3. A 
similar finding has also been concluded from east-
ern Asia26, Iraq and Iran.19
Nearly equal distribution of vacAm1 and va-
cAm2 alleles was encountered in this study. The 
same has been found in Jordan  27. Studies from 
Turkey, Iraq, Iran and Saudi Arabia characterized 
m2 as the main allele.19 In a recent study in China6, 
most of the Chinese, and Uruguayan strains were 
m2, whereas most of the U.S. African strains were 
m1. Previous studies from eastern Asia revealed Amer FA, et al. Helicobacter pylori genotypes 114
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that the m region had country-specific differences.14 
Showing no role in predicting H. pylori virulence by 
vacAm, has been concluded in this work, as was 
previously reported.7 On the other hand, exhibiting 
a major, primary role in that context was formerly 
identified.28
Contrary to studies showing marked differences 
in the occurrence of the i1 and i2 alleles in H. pylori 
strains studied within various populations6, our iso-
lates had nearly equal rates. Meanwhile, we found 
that vacAi1 allele was the only independent marker 
of intensity of illness. Since it has been first reported 
by Rhead, et al. in 2007 its value as a strong and 
independent predictor of H. pylori pathogenicity, has 
been focused upon.5 Authors suggested the vacAi-
region to be a better determinant of disease sever-
ity than vacAs- and m-regions. Review of literature 
has revealed vacAi1 to be linked to more severe 
forms of H. pylori -induced disease 5. In contrast, 
no association was found between vacAi genotypes 
and clinical outcomes in East and Southeast Asian 
countries.29 In fact, more studies are needed to de-
termine whether this new region is a major contribu-
tor to disease state or not.
Dissimilar to studies with Western and Iranian 
strains, which noted that vacAs1-m2 strains varied 
in their i-region genotypes; while vacAs1-m1 strains 
were exclusively i1 5, all possible combination of 
vacAs1 with m and i allels were recognized in this 
work. This goes in accord with others.11 Of note, 
we found vacAs2 allele exclusively with i2 and m2 
alleles, a finding that have been previously identi-
fied.5,6 Nevertheless, the presence of (s2-m1) geno-
types was reported, but with very rare prevalence 
(0-3%).30
All above mentioned geographic differences 
raise the possibility that other bacterial virulence 
factors may influence disease phenotypes. More-
over, other genes with varying degrees of expres-
sion, which have not yet been characterized, may 
exist. Such genes as well as their expression may 
be governed by multiple host geographic origin, en-
vironmental, ethnic and racial make-up along with 
socioeconomic conditions. Further studies are re-
quired to determine the factors involved.
When cagA/vacA were correlated, the major-
ity of our isolates, were of cagA/vacAs1(a)/i1/m1 
genotype. vacAs1(a)/i1/m1 genotype has been sug-
gested to be the most virulent form of the vacuolat-
ing toxin.5 Additionally, we and others5, documented 
a significant association between cagA status and 
vacAs1(a)/i1/m1 genotype in favor of increased dis-
ease severity, as in Table 4. It has been reported31, 
that vacA possibly works as an immune modulator 
altering the immune response to the immunogenic 
cagA. The cytoskeleton of gastric epithelial cells is 
disorganized by cagA, and vacA, which leads to 
amplified cell dispersion and growth. When cagA 
and vacA are combined, they can diminish the ef-
fect of each protein alone, probably leading to much 
more survival of infected host cells. This, conceiv-
ably, occurs by preventing vacA induced apoptosis 
or by inhibiting the vacA induced autophagy path-
way by cagA.
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